Objective Thyroglobulin measurement is the cornerstone of modern management of
differentiated thyroid cancer, with clinical decisions on treatment and follow-up based on the …

The treatment paradigm for thyroid cancer has shifted from a one-size-fits-all approach to
more personalized protocols that range from active surveillance to total thyroidectomy …

Purpose The standard of care for differentiated thyroid carcinoma (DTC) includes surgery,
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …

Objective Ultrasonography‐guided radiofrequency ablation (RFA) has been used to treat
low‐risk small papillary thyroid carcinoma (PTC) and yielded promising results. However …

Context Ultrasonography (US) is considered the most sensitive tool for imaging persistent or
recurrent papillary thyroid cancer (PTC) in the neck. Objective To clarify the usefulness of …

The clinical and epidemiological profiles of differentiated thyroid cancers (DTCs) have
changed in the last three decades. Today's DTCs are more likely to be small, localized …

Background: Neck ultrasound (NUS) is currently seen as a main component of follow-up of
differentiated thyroid cancer (DTC) and is usually performed regardless of non-stimulated …

The current approach for patients with differentiated thyroid carcinoma should be
individualized according to the risk of recurrence, and this stratification could be used to …

ABSTRACT Objective: American Thyroid Association (ATA) low-risk papillary thyroid cancer
(PTC) patients without structural evidence of disease on initial posttreatment evaluation …

Low-risk papillary cancers, which represent the vast majority of thyroid cancers diagnosed
today, do not require aggressive treatment or follow-up. Initial treatment consists of a total …